Information Journal Paper
APA:
CopyKIMURA, M., TAMINAGA, T., TAKATSUKA, Y., TOI, M., ABE, R., & KOYAMA, H.. (2010). RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, EPIRUBICIN, AND FLUOROURACIL CHEMOTHERAPY COMPARED WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL WITH NODEPOSITIVE BREAST CANCER IN JAPAN. BREAST CANCER, 17(3), 190-198. SID. https://sid.ir/paper/568491/en
Vancouver:
CopyKIMURA M., TAMINAGA T., TAKATSUKA Y., TOI M., ABE R., KOYAMA H.. RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, EPIRUBICIN, AND FLUOROURACIL CHEMOTHERAPY COMPARED WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL WITH NODEPOSITIVE BREAST CANCER IN JAPAN. BREAST CANCER[Internet]. 2010;17(3):190-198. Available from: https://sid.ir/paper/568491/en
IEEE:
CopyM. KIMURA, T. TAMINAGA, Y. TAKATSUKA, M. TOI, R. ABE, and H. KOYAMA, “RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, EPIRUBICIN, AND FLUOROURACIL CHEMOTHERAPY COMPARED WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL WITH NODEPOSITIVE BREAST CANCER IN JAPAN,” BREAST CANCER, vol. 17, no. 3, pp. 190–198, 2010, [Online]. Available: https://sid.ir/paper/568491/en